Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program - Ducharme, A; Swedberg, K; Pfeffer, MA (Am Heart J, 2006)
et al.